The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

CDDF Webinar: Treatment of Cancer Patients during the SARS-CoV2 Pandemic: Implications for Clinical Trials

 

The Cancer Drug Development Forum organized a live webinar regarding Treatment of Cancer Patients during the SARS-CoV2 Pandemic: Implications for Clinical Trials on Thursday 2 April 2020 at 6.30PM (CET). This online conference was composed of a 25-minute lecture given by Prof. Dr. Marie von Lilienfeld-Toal followed by a 30-minute discussion session.

SPEAKER

Prof. Marie von Lilienfeld-Toal is Professor of Medicine at the University Clinic of Jena Germany. Her clinical and scientific focus on haematological malignancies and Infectious Diseases in immunocompromised patients with a focus on virology. She is also the author of the

 

 

PROGRAMME

  • 6.30PM-6.35PM (CET): Introduction (Prof. Axel Glasmacher, CDDF)
  • 6.35PM-7.00PM (CET): Lecture (Prof. Marie von Lilienfeld-Toal)
  • 7.00PM-7.30PM (CET): Discussion (moderated by Prof. Axel Glasmacher and Prof. Jaap Verweij, CDDF)

PRESENTATION SLIDES
View speaker’s presentation slides

VIDEO RECORDING

 

 

 

Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752

info@cddf.org
Tel: +32 2 880 62 70